|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | H01J 49/26 | |
| G01T 1/38 | |||
| G01N 24/00 | |||
| C12Q 1/37 | |||
| G01N 33/574 | |||
| G01N 33/68 |
| (11) | Number of the document | 2805346 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13735986.5 |
| Date of filing the European patent application | 2013-01-10 | |
| (97) | Date of publication of the European application | 2014-11-26 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/021074 |
| Date | 2013-01-10 |
| (87) | Number | WO 2013/106603 |
| Date | 2013-07-18 |
| (30) | Number | Date | Country code |
| 201261585202 P | 2012-01-10 | US |
| (72) |
KRIZMAN, David, B., US
HEMBROUGH, Todd, US
THYPARAMBIL, Sheeno, US
LIAO, Wei-Liao, US
|
| (73) |
Expression Pathology, Inc.,
9600 Medical Center Drive, Suite 300, Rockville, MD 20850,
US
|
| (54) | SRM/MRM ASSAY FOR THE INSULIN RECEPTOR PROTEIN |
| SRM/MRM ASSAY FOR THE INSULIN RECEPTOR PROTEIN |